Coronavirus Update: Two Treatments Progress As Moderna/Takeda Investigation Concludes

Takeda and Moderna have identified the source of metallic particles in some lots of mRNA-1273 in Japan, but believe the two deaths identified to be coincidental. Pfizer starts protease inhibitor trial, and Rigel reports fostamatinib data.